Symptom management in patients with multiple sclerosis

Journal of the Neurological Sciences

Volumn 311, Issue SUPPL. 1, 2011, Pages

  Ziemssen, Tjalf ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Depression; Fatigue; Multiple sclerosis; Quality of life; Sexual dysfunction; Spasticity; Symptom management

Indexed keywords

4 AMINOPYRIDINE; ALPHA ADRENERGIC RECEPTOR; AMANTADINE; BACLOFEN; BENZODIAZEPINE; BETA INTERFERON; DANTROLENE; GABAPENTIN; GLATIRAMER; LEVACECARNINE; MONOAMINE OXIDASE A INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TIZANIDINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BALANCE IMPAIRMENT; BLADDER; BLADDER DYSFUNCTION; BLURRED VISION; COORDINATION DISORDER; DEPRESSION; DIPLOPIA; DISEASE COURSE; DISEASE EXACERBATION; FATIGUE; HUMAN; LIFESTYLE MODIFICATION; MOOD DISORDER; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; PAIN; PARESTHESIA; PRIORITY JOURNAL; QUALITY OF LIFE; RIGIDITY; SEXUAL DYSFUNCTION; SPASTICITY; VIBRATION SYNDROME; VISUAL IMPAIRMENT;

ACTIVITIES OF DAILY LIVING; DISEASE MANAGEMENT; HUMANS; MULTIPLE SCLEROSIS; QUALITY OF LIFE; SYMPTOM ASSESSMENT;

EID: 84855216782     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/S0022-510X(11)70009-0     Document Type: Article

References (39)

1. PM Rothwell, Z McDowell, CK Wong, PJ Dorman Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis BMJ 314 1997 1580 1583 (Pubitemid 27229105)
2. M Orme, J Kerrigan, D Tyas, N Russell, R Nixon The effect of disease, functional status, and relapses on the utility of people with multiple sclerosis in the UK Value Health 10 2007 54 60 (Pubitemid 46161095)
3. RD Simmons, KL Tribe, EA McDonald Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management J Neurol 257 2010 926 936
4. MP Amato, G Ponziani, F Rossi, CL Liedl, C Stefanile, L Rossi Quality of life in multiple sclerosis: the impact of depression, fatigue and disability Mult Scler 7 2001 340 344 (Pubitemid 33026260)
5. V Janardhan, R Bakshi Quality of life in patients with multiple sclerosis: the impact of fatigue and depression J Neurol Sci 205 2002 51 58 (Pubitemid 36158993)
6. S D'Alisa, G Miscio, S Baudo, A Simone, L Tesio, A Mauro Depression is the main determinant of quality of life in multiple sclerosis: a classification-regression (CART) study Disabil Rehabil 28 2006 307 314
7. S Fruehwald, H Loeffler-Stastka, R Eher, B Saletu, U Baumhackl Depression and quality of life in multiple sclerosis Acta Neurol Scand 104 2001 257 261 (Pubitemid 32977143)
8. S Kern, W Schrempf, H Schneider, T Schultheiss, H Reichmann, T Ziemssen Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis Mult Scler 15 2009 752 758
9. H Crayton, RA Heyman, HS Rossman A multimodal approach to managing the symptoms of multiple sclerosis Neurology 63 2004 S12 S18
10. SB Patten, CA Beck, JV Williams, C Barbui, LM Metz Major depression in multiple sclerosis: a population-based perspective Neurology 61 2003 1524 1527 (Pubitemid 37505573)
11. AD Sadovnick, RA Remick, J Allen et al. Depression and multiple sclerosis Neurology 46 1996 628 632 (Pubitemid 26099623)
12. L Chwastiak, DM Ehde, LE Gibbons, M Sullivan, JD Bowen, GH Kraft Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample Am J Psychiatry 159 2002 1862 1868 (Pubitemid 35283251)
13. T Ziemssen Multiple sclerosis beyond EDSS: depression and fatigue J Neurol Sci 277 Suppl 1 2009 S37 S41
14. D Lee, R Newell, L Ziegler, A Topping Treatment of fatigue in multiple sclerosis: a systematic review of the literature Int J Nurs Pract 14 2008 81 93
15. P Flachenecker, K Stuke, W Elias et al. Multiple sclerosis registry in Germany: results of the extension phase 2005/2006 Dtsch Arztebl Int 105 2008 113 119 (Pubitemid 351309708)
16. BA Cohen Identification, causation, alleviation, and prevention of complications (ICAP): an approach to symptom and disability management in multiple sclerosis Neurology 71 2008 S14 S20
17. J Greenhalgh, H Ford, AF Long, K Hurst The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis J Neurol Neurosurg Psychiatry 75 2004 577 582 (Pubitemid 38406656)
18. JG Beaumont The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis J Neurol Neurosurg Psychiatry 75 2004 526 527 (Pubitemid 38406644)
19. T Ziemssen, F Kratzsch, M Eulitz, R Kempcke, N Kleiner Development and first evaluation of the new patient management and documentation system MSDS 3D for patients with multiple sclerosis Neurology 74 2010 A554
20. JR Avasarala, AH Cross, K Trinkaus Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis Mult Scler 9 2003 307 310 (Pubitemid 36681900)
21. L Vahter, M Kreegipuu, T Talvik, K Gross-Paju One question as a screening instrument for depression in people with multiple sclerosis Clin Rehabil 21 2007 460 464 (Pubitemid 47064940)
22. M Zorzon, R Zivadinov, A Bosco et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups Mult Scler 5 1999 418 427 (Pubitemid 30028988)
23. M Zorzon, R Zivadinov, L Monti Bragadin et al. Sexual dysfunction in multiple sclerosis: a 2-year follow-up study J Neurol Sci 187 2001 1 5 (Pubitemid 32611651)
24. CC Chao, M DeLaHunt, S Hu, K Close, PK Peterson Immunologically mediated fatigue: a murine model Clin Immunol Immunopathol 64 1992 161 165
25. S Kern, T Ziemssen Brain-immune communication psychoneuroimmunology of multiple sclerosis Mult Scler 14 2008 6 21 (Pubitemid 351541393)
26. C Heesen, H Schulz, M Schmidt, S Gold, W Tessmer, KH Schulz Endocrine and cytokine responses to acute psychological stress in multiple sclerosis Brain Behav Immun 16 2002 282 287 (Pubitemid 35425566)
27. CJ Dickinson Chronic fatigue syndrome - aetiological aspects Eur J Clin Invest 27 1997 257 267 (Pubitemid 27163249)
28. R Djaldetti, I Ziv, A Achiron, E Melamed Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment Neurology 46 1996 632 635 (Pubitemid 26099624)
29. U Roelcke, L Kappos, J Lechner-Scott et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study Neurology 48 1997 1566 1571
30. DH Miller Demyelinating, inflammatory and degenerative diseases Curr Opin Neurol Neurosurg 3 1990 881 883
31. JA Kent-Braun, KR Sharma, RG Miller, MW Weiner Postexercise phosphocreatine resynthesis is slowed in multiple sclerosis Muscle Nerve 17 1994 835 841 (Pubitemid 24235991)
32. LM Metz, SB Patten, CJ Archibald et al. The effect of immunomodulatory treatment on multiple sclerosis fatigue J Neurol Neurosurg Psychiatry 75 2004 1045 1047 (Pubitemid 38869624)
33. T Ziemssen, J Hoffman, R Apfel, S Kern Effects of glatiramer acetate on fatigue and days of absence from work in first-time treated relapsing-remitting multiple sclerosis Health Qual Life Outcomes 6 2008 67
34. T Henze, P Rieckmann, KV Toyka Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society Eur Neurol 56 2006 78 105 (Pubitemid 44492163)
35. DC Mohr, DE Goodkin, W Likosky, N Gatto, KA Baumann, RA Rudick Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis Arch Neurol 54 1997 531 533 (Pubitemid 27204238)
36. DC Mohr, SL Hart, I Fonareva, ES Tasch Treatment of depression for patients with multiple sclerosis in neurology clinics Mult Scler 12 2006 204 208
37. DT Wade, C Collin, C Stott, P Duncombe Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis Mult Scler 16 2010 707 714
38. AD Goodman, TR Brown, LB Krupp et al. Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial Lancet 373 2009 732 738
39. U Dalgas Rehabilitation and multiple sclerosis: hot topics in the preservation of physical functioning J Neurol Sci 311 1 2011 S43 S47